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Abstract 
A variety of evidence suggests that the failure of cellular metabolism is one of the underlying 
causes of neurodegenerative diseases. For example, the inhibition of mitochondrial function 
produces a pattern of cellular pathology in the striatum that resembles that seen in Hun-
tington’s disease. However, neurons can also generate ATP through the glycolytic pathway. 
Recent work has suggested a direct interaction between mutated huntingtin and a key enzyme 
in the glycolytic pathway, glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Yet little 
work has been gone into examination of the cellular pathology that results from the inhibition 
of this alternative energy source. Therefore, the aim of the present study is to characterize 
the cellular pathology that results in the striatum of mice after treatment with a toxin 
(iodoacete, IOA) that compromises anaerobic metabolism. This striatal pathology is com-
pared to that produced by a widely studied blocker of mitochondrial function 
(3-nitropropionic acid, 3-NP).  
We found that low doses of either toxin resulted in significant pathology in the mouse 
striatum. Signs of apoptosis were observed in both experimental groups, although apoptosis 
triggered by IOA treatment was independent from caspase-3 activation. Importantly, each 
toxin appears to produce cellular damage through distinct mechanisms; only 3-NP generated 
clear evidence of oxidative stress as well as inhibition of endogenous antioxidants. Under-
standing the distinct pathological fingerprints of cell loss produced by blockade of oxidative 
and anaerobic metabolisms may give us insights into neurodegenerative diseases.  
Key words: Huntington’s disease, neurotoxins, 3-NP, IOA, apoptosis, neurodegeneration, lipope-
roxidation. 
Introduction 
Failure in energy metabolism has been suggested 
as one of the most important mechanisms underlying 
neural degeneration. Indeed, neurons are exposed to 
oxidative damage due to their high O2 consumption 
to generate the ATP needed to maintain all neuronal 
functions [1]. Disruption of mitochondrial function in 
striatal tissue can produce cellular damage resem-
bling that observed in postmortem tissue obtained 
from patients afflicted by HD [2-4]. GAPDH, an en-
zyme related to anaerobic metabolism, has also been 
implicated in neuronal degeneration [5, 6]. A reduc-
tion in GAPDH activity has been demonstrated in HD 
patients, in transgenic mouse model of HD [7] and 
intrastriatal inhibition of GAPDH produces cell death Int. J. Biol. Sci. 2010, 6 
 
http://www.biolsci.org 
200
[8]. In addition to its glycolytic activity, GAPDH is 
implicated in other cellular functions, for example its 
inhibition induces the activation of apoptotic path-
ways and changes in transcription regulation [9-11].  
Effects of glycolysis inhibition on striatal cell 
death have not been well explored or compared with 
damage produced by the inhibition of oxidative 
phosphorylation. In addition, it is unclear if metabolic 
uncoupling is associated with only necrosis or apop-
tosis, if necrotic and apoptotic death are both present, 
or if other types of cell death such as autophagy are 
happening. In fact, one of the unsolved problems in 
striatal degeneration observed in disorders like HD is 
the precise identification of the cellular process that 
produces neuronal death. Some authors have pro-
posed that cells die through a necrotic process [12, 
13]; still others have suggested that neuronal death is 
apoptotic [14].  
Irreversible or reversible inhibition of mito-
chondria by 3-NP and malonate respectively, has been 
used to uncover cellular mechanisms underlying 
striatal degeneration. These compounds reproduce 
many of the histopathological and neurochemical 
distinctiveness of HD in animal models [15-17]. In 
fact, the use of 3-NP has provided some insights re-
lated to impairment in the oxidative metabolism in 
rodents, although experimental data regarding the 
process that conduces to neuronal death are still con-
tradictory [18]. Neuronal damage produced by 3-NP 
administration can be the consequence of excitotoxic-
ity [19], and calpain activation leading to necrotic 
death [20, 21]. However, several studies show that the 
blockade of oxidative metabolism induces apoptosis 
[22, 23].  
Both oxidative phosphorylation and glycolysis 
can be involved in the pathogenesis of neural dege-
neration in the striatum. However, the type of cellular 
damage induced will depend on several experimental 
factors, namely, if the study was carried out in vitro or 
in vivo, whether rats or mice were used, the experi-
mental procedure involving intrastriatal, or intrape-
ritoneal injections, acute or chronic drug administra-
tion, and if low, sub toxic or toxic concentrations were 
used [4]. 
 The aim of this study was to evaluate and com-
pare neuronal damage induced in C57BL/6 mice, 
after blocking energy metabolism with sub toxic doses 
of 3-NP (which blocks oxidative phosphorylation) or 
IOA (which inhibits glycolysis). We selected mice of 
~1 month of age at the beginning of the experimental 
treatment to be able to compare with other animal 
models where early striatal dysfunction starts at this 
age. 
 
Materials and Methods 
All experiments were carried out following the 
international regulations of Animal Care. C57BL/6 
mice of 30 days old (Harlan, México) were housed in 
plastic cages, in groups of 2, kept at 20°C with a 12/12 
light/dark cycle with free access to food and water. 
Two days after their arrival, animals were assigned to 
one of the following 3 groups: Experimental groups 
receive 3-NP (15 mg/kg), Iodoacetate (10 mg/kg) or 
vehicle (Phosphate Buffer; PB 0.01M; pH 7.4) for 5 
days using intraperitoneal injections. After experi-
mental treatments, mice were assigned at random, to 
perform IHC, histochemical, electron microscopy, or 
biochemical analysis.  
Evaluation of motor disturbances: Motor distur-
bances were evaluated everyday during the treatment 
period and 24 hours after the last treatment, they were 
classified in terms of the presence of dystonia and gait 
abnormalities. Dystonia classification consisted of 
0 = none,  1 = intermittent  dystonia  of  one  limb, 
2 = intermittent dystonia of two limbs or permanent 
dystonia of one limb, 3  =  permanent dystonia. Gait 
anormalities; 0= none, 1= uncoordinated and wob-
bling gait.  
Haematoxylin and Eosin (H&E): T o  ev a l uat e  c el -
lular damage, 3 mice per group were euthanized with 
halothane and perfused through the heart with saline 
solution (NaCl 0.15 M) followed by paraformalde-
hyde (4%) in phosphate buffer (PB, 0.1M, pH 7.4), 
brains were dissected and post-fixed in the same fixa-
tive for two hours at room temperature, and then 
transferred to a sucrose solution (20%). Coronal slices 
(20  μm) were obtained with a microtome (Leica, 
Germany) and mounted in glass slides for staining 
with conventional technique for H&E (H&E kit 75290, 
BIOCARE Medical; Concord, CA). Then tissue was 
covered with Cytoseal®.  
Immunohistochemistry (IHC): Caspase-3 and cas-
pase-9 expression was documented by IHC. The IHC 
procedure was carried out as previously described 
[24]. Briefly, coronal tissue sections (20 μm), adjacent 
to those used for H&E were incubated at 4°C in 
blocking serum overnight. Thereafter, tissue sections 
were incubated for 24 hr in primary antibodies 
(Chemicon, International, Inc, Temecula CA, USA) 
raised against caspase-3 (1:100, AB3623 Polyclonal 
Antibody), caspase-9 (1:500, MAB4709 monoclonal 
antibody) or GAPDH (1:100, MAB374 Monoclonal 
Antibody), all diluted in blocking buffer. After rinse, 
tissue slices were incubated with the corresponding 
secondary antibodies (1:500) coupled to biotin and 
diluted in blocking solution. The AB Vector kit (Vec-
tor Laboratories, Inc. Burlingame, CA, USA) was used Int. J. Biol. Sci. 2010, 6 
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to detect biotinylated antibodies following the manu-
facturer’s instructions. Tissue slices were mounted 
and cover slipped with mounting medium (Fisher 
Scientific, Pittsburgh, PA, USA). Control experiments 
were carried out by pre-absorbing the primary anti-
bodies with their corresponding antigens omitting the 
primary antibody or the primary and secondary an-
tibodies.  
  Terminal deoxynucleotidyl transferase dUTP nick 
end labeling ( TUNEL) assay: T i s s u e  s l i c e s  a d j a c e n t  t o  
those used for evaluating Caspases immunoreactivity 
were used to detect DNA fragmentation by TUNEL 
assay, following supplier instructions (Apoptosis de-
tection kit, TA300, R&D Systems, Minneapolis, MN, 
USA). To finish, tissue was rinsed, dried and cover-
slipped with Permount (Fisher Scientific, Pittsburgh, 
PA, USA). TUNEL-labeled cells which displayed 
densely labeled, small particles in the cytoplasm 
(apoptotic bodies), and different types of chromatin 
condensation around the margin of the nucleus 
forming either crescent caps or rings, were quantified 
per field by light microscopy.  
Cell counting: To count damaged cells, positive 
cells to IHC procedures and TUNEL assay, images 
were obtained and digitized using an image analysis 
system (Metamorph 4.0, Universal Imaging) con-
nected to a microscope equipped with a video camera 
coupled to a computer monitor. The analysis con-
sisted of obtaining squared probes of 1mm2 in 40X 
magnification to determine damaged or immunos-
tained cells. The number of cells was obtained as an 
average of 3 fields per section, 10 sections per brain 
and 3 mice per experimental group. 
Electron microscopy: To evaluate ultrastructural 
changes 3 animals of each experimental group were 
perfused with paraformaldehyde 4% and glutaral-
dehyde 2.5 % in phosphate buffer (0.1M, pH 7.4). 
Neostriatum was dissected, post fixed for 3 hours and 
cut in small segments. Later on, tissue slabs were 
rinsed and included in epon resin to obtain ultrathin 
section (60 nm). Slices were visualized with the aid of 
electron microscopy and micrographs were taken for 
further analysis. Sections were subject to blind ex-
amination regarding the experimental protocol and 
scored as follows: Vacuolization: 0 = none, 1 = mild, 
2 = moderate and 3 = severe. 
 Ribonucleic  acid ( RNA) extraction and Reverse 
Transcription-Polymerase Chain Reaction (RT-PCR): To-
tal RNA was isolated from 0.5 g samples of frozen 
striatal tissue (3 mice brains from each experimental 
condition), and the extraction was carried out with the 
TRIzol reagent method using the Total RNA Isolation 
Reagent  (Invitrogen, Life Technologies, Inc.). RNA 
concentration was calculated from the optical density 
at 260 nm, and purity was determined by 260nm 
/280nm absorbance.  
Quantitation of gene transcripts by real-time 
RT-PCR analysis: Total RNA (~300ng) from each sam-
ple was reverse transcribed (RT) using oligo(dT)12–18 
primer and SuperScript I RT kit (Life Technologies), 
and 1 μg/μl RNA for 50 min at 42°C. Quantitative 
real-time PCR was performed using SYBR Green 1 μl, 
PCR buffer 1X 2.5 μl, 50 mM MgCl2 1 μl, 100 μM 
dNTPs 1 μl, 1 unit platinum Taq DNA polymerase, 50 
μmol/μl gene-specific forward and reverse primers, 
and 50 ng cDNA. The reaction conditions were as 
follows: 4 min at 94°C (denaturalization), 1 min at 
94°C, 1 min annealing temperature, and 1 min at 72°C 
(30 or 35 cycles). Gene-specific PCR products for 
GAPDH were continuously measured by a Rotor 
Gene RG 3000 detection system (Corbett Research, 
Australia). Three replicates for each experimental 
sample were performed, and differences were as-
sessed with the 2_ΔΔCT method [25]. Using the 2_ΔΔCT 
method, the data are presented as the fold change in 
gene transcripts normalized to the housekeeping gene 
as one by definition [26]. Then computed analysis was 
used to reflect the relative mRNA transcript levels to 
demonstrate the fold change of GAPDH gene tran-
s c r i p t s  i n  C 5 7 B L  / 6  m i c e  t h a t  r e c e i v e d  e i t h e r  t o x i n  
compared with the expression of β-actin gene. The 
sequences of the specific primers and alignment con-
ditions used are listed in Table 1. Data are presented 
as the fold change. 
Table 1. Primer sequences Real Time PCR 
Gene   Primer (5’-3’)   Align
ment 
(°C)  
Product 
size (pb) 
β -actin   F-gTg gC CgC TCT Agg CAC CAA   56°C   536 pb  
R-CTC TTT gAT TgC ACg CAC gAT 
TTC  
GAPDH   F-CTC ATg ACC ACA gTC CAT gC   54°C   201 pb  
R-CAC ATT ggg ggT Agg AAC AC  
 
Evaluation of nitric oxide (NO) levels 
 NO: NO production was evaluated indirectly by 
measuring nitrates in serum. Blood samples from 
treated (3-NP, n=5; IOA, n=5) and control (n=5) mice 
were incubated for about 15 minutes at 37°C, after-
ward the blood was centrifuged (12000 rpm) for 15 
minutes. To quantify nitrates, 0.1% of napftiletilen-
diamine dihydrochloride was mixed in a plate of 96 
wheels, with serum samples (100 µl, different con-
centrations) and 75µl of Griess reagent, incubated at 
room temperature for 10 min, and measured in 550 
nm-620 nm in an ELISA lector. Absorbance spectrum 
of the colored azo compounds was quantified using Int. J. Biol. Sci. 2010, 6 
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serial dilutions of sodium nitrite as standard reference 
curve. Data are expressed as absorbance units. 
Evaluation of lipid peroxidation 
 LPO: Lipid peroxidation was measured by the 
fluorescence of lipid peroxidation products, briefly 
striatal tissue from control (n=5), 3-NP (n=5) and IOA 
(n=5) treated mice was weighed and homogenized in 
3 ml of saline solution (0.9% NaCl). Aliquots of 1 ml 
were added to 4 ml of a chloroform–methanol mixture 
(2:1 v/v). After stirring, the mixture was kept on ice 
(30 min) to permit phase separation and then, the 
fluorescence of the chloroform layer was measured in 
a Perkin–Elmer LS50B luminescence spectrometer 
(excitation 370 nm and emission 430 nm wave-
lengths). Results are expressed as fluorescent units/g 
of wet tissue.  
Evaluation of antioxidant enzymes activation 
  Five mice per group were used to evaluate the 
activity of antioxidant enzymes 
 CAT activity: Catalase activity was determined at 
25ºC analyzing the decomposition of H2O2 used as the 
substrate of the enzyme contained in the homoge-
nized striatal sample [27]. Kinetics was analyzed by 
the equation, k= 2.3/t log Ao/A where k was the first 
point and t was the time when H2O2 was reduced by 
catalase activity. Results are expressed in k/mg of 
protein. 
 GPx activity: 30 μl of homogenized striatal tissue 
(control n=5, 3-NP, n=5; IOA, n=5) was incubated in 
the following solution: 0.5ml glutathione (GSH; 2.0 
mM), 0.5 ml Na phosphate buffer (0.40 M, pH 7) con-
taining EDTA (4 x 10-4 M), 0.25 ml NaN2 (0.1M) in 
water. After 5 min at 37 ºC, 0.1 ml H2O2 (0.2 mM) was 
added. Then, 1 ml of metaphosphoric acid was added 
and centrifuged (3500 rpm, 15 min). Free GSH was 
determined in 1ml of the centrifuged solution in 1ml 
of PB, 0.5 ml of 5, 5-di-tiobis-2-nitrobenzoic (DTNB). 
Absorbance was measured at 412 nm in a U.V. spec-
trophotometer (Lamda 20, Perkin-Elmer).  The de-
crease in absorbance was directly proportional to the 
GPx concentration.  
 GSR activity: Glutathione reductase activity was 
measured by the method of Carlberg and Mannervik 
[28]. The enzyme activity was quantified at 25 °C by 
measuring the disappearance of NADPH at 340 nm. 
Optical density was recorded at 4 minutes and data 
expressed in mU/mg of protein. 
  Total SOD activity: The method used for deter-
mining SOD activity was based on nitroblue tetrazo-
lium (NBT) reduction [29]. Xanthine–xanthine oxidase 
was utilized to generate a superoxide flux in the 
striatal sample (control, 3NP or IOA). The absorbance 
obtained from NBT reduction to blue formazan by 
superoxide was determined spectrophotometrically 
(560 nm, BEKMAN DU-64) at room temperature. One 
unit (U) of SOD activity was defined as the amount 
that reduced the absorbance change by 50%, and re-
sults were normalized on the basis of total protein 
content (U/mg protein) in each sample.  
 Copper–zinc-superoxide dismutase (CuZn-SOD) ac-
tivity: It was differentiated from manganese supe-
roxide dismutase (Mn-SOD) by the addition of 2 mM 
sodium cyanide, to inhibit the activity of CuZn-SOD. 
CuZn-SOD activity was calculated as the difference 
between total SOD and Mn-SOD activity. Data were 
normalized on the basis of total protein content and 
expressed as U/mg protein.  
Statistical Analysis: Damage induced by 3-NP 
treatment in mice varies from mouse to mouse; also 
there are no studies carried out in vivo analyzing 
striatal damage in the presence of low doses of IOA 
[30], then to visualize all data distribution with our 
experimental conditions, data are presented in box 
plots unless otherwise indicated. Experiments on data 
normally distributed were compared using ANOVA 
followed by Bonferroni post hoc tests. Kruskall-Wallis 
One Way Analysis Of Variance followed by Dunnet 
post hoc comparisons were used if the normality test 
failed. The statistical analysis was conducted using 
SigmaStat statistical software for Windows, version 
2.03 (Systat Software, Inc.) and p<0.05 was considered 
to be statistically significant. 
Results 
Motor disturbances in 3-NP and IOA treated animals. 
Treating animals with 15 mg/kg of 3-NP or 10 
mg/kg of IOA for 5 days did not produce gait ab-
normalities or dystonia during the treatment period. 
In pilot experiments higher doses of 3-NP and IOA (20 
mg/kg and 15 mg/kg, respectively), were utilized 
and motor disturbances were observed, but high an-
imal mortality was also obtained (~60 %, data not 
shown). Lower doses of 3-NP (10mg/kg) or IOA 
(5mg/kg) did not produce tissue damage in compar-
ison to control group. A combination of 3-NP and IOA 
together was given in some mice, but they died the 
following day. For those reasons, selected drug con-
centration were 15 (3-NP) and 10 (IOA) mg/kg admi-
nistrated for 5 days, and only one toxin was adminis-
tered per animal group or the drug vehicle to control 
mice.  
Cellular damage in 3-NP and IOA treated animals. 
To evaluate striatal damage, tissue slices were 
stained with H&E histochemical reaction. Figure 1, 
shows cellular damage visualized with H&E. Tissue Int. J. Biol. Sci. 2010, 6 
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from control animals exhibited striatal neurons with 
normal (n) appearance (Fig. 1A). IOA and 3-NP 
treated mice, displayed significantly more damaged 
cells (Fig. 1A-D) than control tissue (Kruskal-Wallis, 
One Way Analysis of Variance on Ranks, H2=14.232, 
p<0.001). Multiple comparisons carried out with 
Dennett’s method, revealed significant differences 
between each experimental group and the control 
group (IOA vs. control q=3.72, p<0.05; 3-NP vs. control 
q=2.287, p<0.05). 
TUNEL assay in 3-NP and IOA treated animals.  
Nuclei alterations may be related to apoptotic 
damage, therefore TUNEL assay was carried out to 
evaluate if apoptosis was induced in our experimental 
manipulations. Figure 3 illustrates representative 
images obtained from brain slices of control (Fig. 3A), 
IOA (Fig. 3B) and 3-NP (Fig. 3C) treated mice. Figure 
3D shows that both, IOA (28 %) and 3-NP (57 %) 
treatments significantly increased TUNEL positive 
cells, in comparison with control tissue 
(Kruskal-Wallis One Way Analysis of Variance on 
Rank, H2= 53.010, p<0.001, Multiple Comparisons 
versus Control Group Dennett’s method, q'=4.283 
(IOA) and q'=7.206 (3-NP), p<0.05). 
 
 
 
 
 
Figure 1. Light micrographs of H&E stained striatal tissue of control (A), IOA (B), or 3-NP (C) treated mice. No histological 
abnormalities were present in the tissue from control brains and neurons exhibited normal (n) appearance, arrows point to 
normal cells (A). Striatal tissue from IOA treated mice exhibited some healthy cells, but there are several damaged cell (d) 
with condensed and pyknotic nuclei (B). Striatal tissue from mice treated with 3-NP exhibited damaged cells (d) with 
condensed and pyknotic nuclei and different degrees of neurodegeneration (C). Box plots represent Median, 25% and 75% 
of the damaged cells in each group (D) and demonstrated that IOA and 3-NP treated animals showed more damaged cells 
than control group (**p<0.001). Scale bar is 20 μm and magnification was 40X. Int. J. Biol. Sci. 2010, 6 
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Figure 2. Electron microscopy analysis of cellular damage. A and D exhibit electron micrographs of control tissue. Cells 
show well defined nuclei with normal appearance (A) and mitochondria with normal membrane and clear crest (D). Tissue 
from IOA treated mice (B) shows altered nuclei; chromatin is oriented towards nuclear membrane, mitochondria are 
swollen and intracellular edema can be observed (E). Tissue of 3-NP treated mice (C) was characterized by altered nuclei 
and chromatin oriented to nuclear membrane. Nuclear membrane is also damaged. Prominent vacuoles are observed (F), as 
well as swollen mitochondria. Magnification in A, B and C is 7000X, and in D, E, and F is 12000X. 
 
Figure 3. Light micro-
graphs of TUNEL posi-
tive cells in the striatal 
tissue of control (A), 
IOA (B), or 3-NP 
treated mice (C). Tissue 
of IOA treated mice (B) 
as well as 3-NP treated 
tissue, exhibited more 
apoptotic cells (arrows) 
than control tissue 
(**p<0.001). Box plots 
expressed data in Me-
dians, 25% and 75% of 
stained cells. Pictures 
were taken at 40X 
magnification. Scale bar 
ix 40 μm.  
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Figure 4. Light micrographs of Caspases 9 and 3 immunohistochemical localization in the striatal slices of control (A), IOA 
(B), or 3-NP treated mice (C). (Top) Analysis of the number of positive cells for caspase-9 showed no statistically significant 
changes among groups (D). (Bottom) Caspase-3 immunohistochemical localization in the striatal tissue of control (E), IOA 
(F), or 3-NP treated mice (G). Analysis of the number of positive cells for caspase-3 increased significantly in the 3-NP 
treated group (**p<0.001, H). Box plots expressed data in Medians, 25% and 75% of stained cells. Pictures were taken at 40X 
magnification. Scale bar is 30 μm. Int. J. Biol. Sci. 2010, 6 
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Caspases activation in IOA and 3-NP treated animals. 
 Apoptosis can be triggered by caspases activa-
tion or by other intracellular mechanisms; we esti-
mated caspase-9 and caspase-3 involvement in the 
apoptotic damage produced by 3-NP and IOA, by 
means of IHC procedures in striatal slices adjacent to 
those used for TUNEL assay. Figure 4 (top) shows 
representative images of immunostained tissue for 
Caspase-9 from control (Fig. 4A), IOA (Fig. 4B), and 
3-NP (Fig. 4C) treated animals. There were no signif-
icant differences in the number of positive cells for 
caspase-9 between groups (Kruskal-Wallis One Way 
Analysis of Variance on Rank, H 2= 2.499, P=0.287, 
Fig. 4 D). Figure 4 (bottom) illustrates representative 
images obtained from slices of control (Fig. 4E), IOA 
(Fig. 4F), and 3-NP (Fig. 4G) treated animals stained 
with caspase-3 antibody. Figure 4H shows that the 
number of positive cells for caspase-3 significantly 
increased in the 3-NP group (Kruskal-Wallis One Way 
Analysis of Variance on Rank, H2= 54.275, P <0.001, 
Multiple Comparisons versus Control Group, Den-
nett’s Method, q' =6.661, P<0.05), but not in IOA 
treated animals (q' =0.6671, p>0.05). 
Expression of mRNA GAPDH by Polymerase Chain Reaction 
(PCR) in IOA and 3-NP treated animals 
GAPDH enzyme has been suggested as a mul-
tifunctional protein whose role is wider than that re-
lated to glycolysis, its deregulation has been linked to 
apoptosis induction and its expression may also be 
modified by altering energy and/or oxidative meta-
bolism. Consequently, mRNAGAPDH expression levels 
were evaluated and compared in both treatments. 
Real time RT-PCR showed differences in the expres-
sion levels of mRNAGAPDH (F2= 85.894, p=0.002, Fig. 
5B) between groups. There was a significant increase 
in mRNAGAPDH levels in the 3-NP treated group when 
compared to control (t= 8.773, p=0.009; Bonferroni`s 
t-test) and IOA treated groups (t=12.820, P=0.003, 
Bonferroni`s t-test). IOA treated mice striatal tissue 
also exhibited differences in comparison to control 
group (t=5.033; p=0.045; Bonferroni`s t-test).  
 
 
Figure 5. Expression levels of striatal mRNA
GAPDH by PCR. (A) PCR products of GAPDH in control, IOA and 3-NP treated 
groups stained with SYBR green on a 2 % agarose electrophoresis gel. (B) Quantitative PCR analysis of mRNA
GAPDH levels 
from mice striatum of control, IOA and 3-NP treated groups displayed significant differences in the gene expression among 
groups (**p<0.002).  
 Int. J. Biol. Sci.
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Figure 7. Evaluation of CAT, GPx, and GSR activity. Activity of CAT (A), GPx (B) and GSR (C) is illustrated, IOA did not 
change any of the enzymes activity, while 3-NP significantly reduced CAT (** p<0.001, A) and GPx (*p< 0.004, B) activity 
levels.  
 
 
Figure 8. Evaluation of total SOD, CuZn-SOD, and MnSOD activity. Activity of Total SOD (A), CuZn-SOD (B) and 
MnSOD (C) is displayed, IOA did not change any of SOD enzymes activity, while 3-NP significantly reduced Total SOD(** 
p<0.001, A) and CuZn-SOD (** p< 0.001, B) activity levels. Int. J. Biol. Sci. 2010, 6 
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Superoxide dismutase (SOD) 
  The other antioxidant enzyme which catalyzes 
the dismutation of superoxide into oxygen and hy-
drogen peroxide is the SOD. Subsequently, enzymatic 
activities of total SOD, CuZn-SOD, and Mn-SOD were 
measured. 
Total SOD 
 Total SOD activity changed significantly among 
evaluated groups (Fig. 8A, One Way Analysis of Va-
riance, F2= 28.20, p<0.001). There was a decrease in 
total SOD activity in 3-NP treated group in compari-
son to control group (Control vs 3-NP, t=4.997, 
p<0.001; Bonferroni`s t-test), but there were no dif-
ferences between control and IOA treated group 
(Control vs. IOA, t=1.183, p=0.511; Bonferroni`s t-test).  
Copper-zinc and Mn isoform of SOD  
  Similarly as total SOD, changes (F2=30.154, 
p<0.001) in the activity of the CuZn-SOD was found. 
Multiple Comparisons analysis demonstrated that 
CuZn-SOD activity was significantly different in 3-NP 
treated mice when compared to Control  group 
(t=5.537, p<0.001; Bonferroni`s t-test; Fig. 8 B), but 
there were no differences between Control and IOA 
treated groups (t=716, p=0.970, Bonferroni`s t-test). 
Mn-SOD activity was not different among evaluated 
groups (One Way Analysis of Variance; F2=1.313, 
P=0.298, Fig. 8C). 
Discussion    
  The present work compares in detail cellular 
damage and the activity of antioxidant enzymes in 
response to the inhibition of oxidative phosphoryla-
tion or glycolysis using low sub chronic doses of 3-NP 
or IOA respectively. Our main finding is that each 
toxin produces striatal apoptotic damage through 
different mechanisms.  
Motor disturbances 
  Motor disturbances evaluation carried out with 
our experimental protocol did not display major mo-
tor disturbances, like dystonia and gait abnormalities. 
These results support the idea that the development 
of overt clinical signs, including weight loss and mo-
tor dysfunction, occurs when massive degeneration 
has taken place [4]. Evaluations of longer times after 
the last injection are currently carrying on, analyzing 
motor symptoms. 
Cellular damage 
  Oxidative phosphorylation or glycolysis inhibi-
tion elicited cellular damage documented with H&E 
staining (Fig. 1B and 1C), and electron microscopy 
(see below). Several experimental reports describe 
that cell’s alteration in neurodegenerative diseases 
induce neurons to a necrotic or apoptotic death [1, 2]. 
Thus, interrupting mitochondrial function with repe-
titive doses of 3-NP produced cellular damage like 
that earlier reported [3, 31]. Neuronal damage pro-
duced by intraperitoneal administration of 3-NP in 
low doses, has been described at the onset of the 
neurodegenerative process [4], is restricted to striatal 
calbinding positive cells (unpublished data from our 
lab), may initiate necrotic death by excitotoxicity [19], 
and triggers apoptotic pathways in mice like it does in 
rats [32]. 
  Regarding mechanisms responsible for striatal 
cellular alteration triggered by glycolysis inhibition, 
our data demonstrates that IOA induces apoptosis 
(Fig.1B, 2B and 3B). Those results suggest that changes 
in energy metabolism may also underlie cellular 
dysfunction at the striatum [5]. 
  TUNEL assay in our experiments revealed that 
inhibition of both, oxidative phosphorylation and 
glycolysis trigger apoptotic pathways (Fig. 3B and 
3C). To analyze if caspases activation was involved in 
the apoptotic damage, immunehistochemical expres-
sion of caspase-3 and caspase-9 were carried out. 
Caspase-9, an initiator caspase [33], did not display 
significant differences in its expression after inhibition 
of oxidative phosphorylation or glycolysis. It is poss-
ible that by the time its expression was evaluated, it 
had already been inactivated. Conversely, a signifi-
cant increase in the number of immunostained cells 
for caspase-3 was exhibited in tissue from 3-NP 
treated group but not in the IOA-treated group.  
  In previous experiments 3-NP did not show 
caspase-9 or caspase-3 expression in striatal cells in 
culture [34], nonetheless in vivo, caspase-9 activation 
was induced with two intraperitoneal injections 
(acute model) of 3-NP, or with constant infusion for 5 
days (chronic model) through osmotic pumps. In the 
same study, caspase-3 was induced in the acute but 
not in the chronic model [20]. 3-NP administration 
scheme in the present study was neither acute nor 
constant, instead 3-NP was given daily in low doses 
(15 mg/kg), once a day, for 5 days; we considered our 
treatment as a sub-chronic administration, thus dis-
crepancies between our results and those earlier re-
ported, must be due to differences in experimental 
design. 
  In the present study, each toxin systemically 
administered, produced apoptosis as previously re-
ported [32, 35]; however, they activate different cel-
lular apoptotic pathways. It was recently demon-Int. J. Biol. Sci. 2010, 6 
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strated that IOA produces neuronal death by ROS 
formation in vitro [36]; in our conditions there were no 
changes in NO, LPO or in antioxidant enzymes activ-
ity after IOA administration in vivo. 
  Besides apoptotic damage, some signs of ne-
crotic damage were manifested at the ultra struc-
tural level in 3-NP treated animals, for example, 
cellular edema and altered nuclei with chromatin to-
wards nuclear membrane might be produced by wa-
ter accumulation inside the cell, resulting from an 
alteration in mitochondrial function [37]. 3-NP treat-
ment indirectly alters ion gradients due to energy 
depletion in neurons, leading to a prolonged increase 
in intracellular Ca2+ and Na+, producing cell edema 
[38]. Nuclear changes observed in the tissue treated 
with 3-NP may be induced by the release of 
pro-apoptotic molecules that participate in nuclear 
condensation and its fragmentation [39]. 
  Inhibition of GAPDH with IOA did not induce 
necrotic damage; nevertheless, it was interesting to 
observe the presence of vacuolization in response to 
IOA or 3-NP treatments, since it suggests that some 
type of autophagy is activated after each toxin treat-
ment. In normal conditions, damaged organelles, cell 
membranes and proteins are degraded by autophagy; 
however, a failure in autophagy could be responsible 
for protein accumulation in damaged cells [40]. In-
deed autophagy has been related to cell destruction in 
several types of programmed cell death [41]. 
GAPDH role in cellular damage 
  The study of glycolysis inhibition at the brain 
with IOA has been carried out previously in vitro [30, 
42, 43]; but there was a lack of information about 
glycolysis inhibition in vivo, and its effects on striatal 
tissue. Also, there were no previous studies evaluat-
ing changes of the glycolytic enzyme GAPDH levels 
when oxidative phosphorylation was blocked or in-
activated. We found significant differences in GAPDH 
gene expression between IOA and 3-NP treatment. 
While IOA reduced mRNAGAPDH expression, 3-NP 
treated group increased GAPDH gene expression. 
Although an increase in GAPDH transcription would 
be expected to compensate the reduced activity of the 
enzyme after IOA treatment, the truth is that IOA is 
an irreversible inhibitor of GAPDH [43], then reduced 
mRNAGAPDH expression with chronic administration 
of IOA is also understandable. On the other hand, 
there are at least two explanations for the increase of 
mRNAGAPDH expression levels in the presence of 
3-NP. Inhibition of mitochondrial respiration activates 
other metabolic pathways such as glycolysis in glial 
cells [44]; therefore it is possible that increased level of 
mRNAGAPDH in the 3-NP treated group was due to 
glycolysis activation in glial cells, because for RT-PCR 
procedures the whole striatal tissue was processed. 
An alternative explanation is related to other GAPDH 
functions; as known, besides its role in glycolysis, 
GAPDH is involved in DNA transcription, replica-
tion, reparation and apoptotic induction [9-11], in fact 
GAPDH increase is found in apoptotic cell death [45]; 
finally an increase of mRNAGAPDH levels have also 
been observed in non-neuronal tissue after oxidative 
stress induction [46]. Therefore, mRNAGAPDH increase 
in striatal tissue of 3-NP treated mice may indicate 
neuronal damage. Further experiments should be 
carried out to probe whether mRNAGAPDH increase in 
the presence of 3-NP is related to neuroprotection or 
to neurodegeneration. 
Effects on NO and LPO production 
 In previous experiments, administration of both 
3-NP and IOA increases free radicals production 
[46-47]. Superoxide anion and hydrogen peroxide, 
combined with other reactive species as nitric oxide 
(NO) produce peroxynitrite [48], and are capable of 
attacking cell membrane lipids and proteins. 3-NP 
increases oxidative stress because interferes with 
electron transport cascade, which results in a cellular 
energy deficit [49]. 
  In the present study, 3-NP and IOA did not 
produce significant augmentation of NO, however 
3-NP increased LPO. Previous reports looking at the 
involvement of NO in the toxicity of 3-NP have not 
helped in reaching clear conclusions [50], but it has 
been suggested that 3-NP acts as NO donor, increas-
ing nitro anions (NO-) levels [47, 49]. 3-NP also in-
duces Ca2+ increase, and interferes with mitochondrial 
function, increasing mitochondrial O2·- which in turn 
interacts with NO to form more NO- which interacting 
with arachidonic acid induces lipid peroxidation, 
which may explain LPO increase in the 3-NP treated 
group (Fig. 6B).   
  IOA inhibits glycolysis, decreases ATP produc-
tion [30] and increases free radicals in vitro [36], we 
did not evaluate directly changes in free radicals 
formation, but at the doses evaluated and administra-
tion route, IOA did not produce changes in NO or 
LPO levels.  
Effects on antioxidant enzymes activation  
  To better understand the process underlying 
energy uncoupling we searched for mechanisms of 
cellular protection, evaluating the activity of the an-
tioxidant enzymes CAT, GPx, GSR, Total SOD, 
CuZn-SOD and Mn-SOD, which counteract the dele-
terious effects of reactive oxygen species and oxida-Int. J. Biol. Sci. 2010, 6 
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tive stress. In our experimental conditions, 
IOA-treated animals did not exhibit changes in any of 
the enzymes evaluated. This finding supports the 
conclusion that IOA effects on striatal tissue result 
from the activation of different cellular pathways than 
those activated in 3-NP treated animals [43]. 
 On the contrary 3-NP treated group exhibited a 
reduction in CAT, GPx, Total SOD and CuZn-SOD 
enzymatic activities while Mn-SOD, did not change. 
We do not have an answer to explain it, but Supe-
roxide Dismutases convert superoxide radicals to 
hydrogen peroxide, after that, glutathione peroxidase 
and catalase converts H2O2 to water. If one of these 
enzymatic reactions fails, antioxidant mechanisms fail 
too, leading to neuronal damage [51]. Decrement in 
CuZn-SOD activity, as the one we observed in the 
present study, has been reported in animal models of 
Parkinson’s disease [52] and Huntington’s disease 
[53]. Then, 3-NP treated mice possibly were subject to 
oxidative stress. These results are consistent with the 
hypothesis which suggests that in cell degeneration 
there is an imbalance between ROS production and 
the antioxidant defense system function. 
Conclusions  
 Several studies have revealed that energy defi-
ciency causes neurodegenerative diseases; however, 
energy sources may come from two different routes, 
glycolysis and oxidative phosphorylation. In our ex-
perimental conditions the inhibition of glycolysis or 
oxidative phosphorylation induced cellular damage; 
but, glycolysis inhibition did not produce striatal al-
terations to the extent that oxidative phosphorylation 
inhibition did. This information should be taking in 
count when designing experimental protocols to in-
duced striatal damage where a failure in bioenergetics 
has been presumed.  
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